Bicalutamide Tablet
Product Images NDC 51407-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 51407-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-010-30 (pl) .jpg (51407 010 30 (pl))

51407-010-30 (pl) .jpg (51407 010 30 (pl))
Label for Bicalutamide Tablets USP 50 mg, oral tablet form, containing 30 tablets per bottle. Manufactured by Corden Pharma GmbH, Germany, and marketed by Golden State Medical Supply, Inc. The label includes storage instructions, a barcode, and states 'Rx only.'*
FDA Label Image

Ani (Ani)

FDA Label Image

Chem (Image 01)

Chem (Image 01)
Chemical structure of Bicalutamide shown with molecular formula C18H14N2O4F4S. The diagram depicts key functional groups including trifluoromethyl, cyano, sulfonyl, and fluorophenyl groups attached to the core structure.*
FDA Label Image

Figure-1 (Image 02)

Figure-1 (Image 02)
A survival curve graph comparing the proportion surviving over time for two treatments: Bicalutamide plus LHRH-A (solid line) and Flutamide plus LHRH-A (dashed line). The x-axis represents days to death up to 1825 days, and the y-axis represents the proportion surviving from 0.1 to 1.0.*
FDA Label Image

Figure-2 (Image 03)

Figure-2 (Image 03)
A line graph comparing the proportion of patients not progressing over time between two treatments: Bicalutamide plus LHRH-A and Flutamide plus LHRH-A. The x-axis represents days to progression, ranging from 0 to 1825 days, and the y-axis represents the proportion not progressing, from 0.0 to 1.0. Both treatments show a gradual decline in progression-free proportion over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.